PWA
RVMD icon

Principia Wealth Advisory’s Revolution Medicines RVMD Stock Holding History

Principia Wealth Advisory’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$936 Buy
5
+1
+25% +$146 ﹤0.01% 778
2026
Q1 		$389 Buy
+4
New +$404 ﹤0.01% 882
2025
Q3 		– Sell
-14
Closed -$515 – 1006
2025
Q2 		$515 Buy
+14
New +$538 ﹤0.01% 726

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Principia Wealth Advisory's RVMD Position: Q2 2026 in Review

Principia Wealth Advisory increased its Revolution Medicines (RVMD) stake by 25% in Q2 2026, buying an estimated $146 and bringing the position to 5 shares worth $936. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Principia Wealth Advisory first reported a position in RVMD in Q2 2025 and has held it in 3 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Principia Wealth Advisory held 5 shares of Revolution Medicines worth $936 as of Q2 2026.
  • Principia Wealth Advisory bought 1 Revolution Medicines share in Q2 2026, an estimated $146.
  • Revolution Medicines made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #778 holding.
  • Principia Wealth Advisory first reported a position in Revolution Medicines in Q2 2025 and has held it in 3 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.